IGC Pharma Analyst Price Targets - Benzinga

IGC Pharma Inc

IGCAMEX

Trade with Public

Trade with Public

$0.2460

-0.0017-0.69%

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 주식 보고서

IGC Pharma Analyst Price Targets - Benzinga

IGC Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for IGC Pharma (IGC).

Price Target Range — 9 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingBuy# Analysts2Avg. Consensus PT$5

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 26, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$6→$6
Jun 8, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$5→$6
Apr 8, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$5→$5
Feb 23, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$5→$5
Dec 9, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$5→$5
Aug 26, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$4→$5
Mar 6, 2025	Alliance Global Partners	James Molloy	Maintained	Buy	$4
Feb 24, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$4→$4
Dec 5, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$4→$4
Sep 3, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$4→$4
Jul 29, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$3→$4
Jul 17, 2024	Alliance Global Partners	James Molloy	Initiate	Buy	$4
Jun 21, 2024	Ascendiant Capital	Edward Woo	Maintained	Buy	$3

Analyst Ratings News

PRO
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $6

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $5.5 to $6.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5.5

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $5.25 to $5.5.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5.25

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $5 to $5.25.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4.75 to $5.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $4.5

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4.25 to $4.5.

Benzinga Newsdesk

PRO
Alliance Global Partners Reiterates Buy on IGC Pharma, Maintains $3.5 Price Target

Alliance Global Partners analyst James Molloy reiterates IGC Pharma (AMEX:IGC) with a Buy and maintains $3.5 price target.

Benzinga Newsdesk